NM_004329.3:c.-267-25895T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004329.3(BMPR1A):​c.-267-25895T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 152,208 control chromosomes in the GnomAD database, including 1,909 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1909 hom., cov: 32)

Consequence

BMPR1A
NM_004329.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.404

Publications

6 publications found
Variant links:
Genes affected
BMPR1A (HGNC:1076): (bone morphogenetic protein receptor type 1A) The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]
BMPR1A Gene-Disease associations (from GenCC):
  • generalized juvenile polyposis/juvenile polyposis coli
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp
  • juvenile polyposis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • polyposis syndrome, hereditary mixed, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hereditary mixed polyposis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • pulmonary arterial hypertension
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.22 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004329.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMPR1A
NM_004329.3
MANE Select
c.-267-25895T>C
intron
N/ANP_004320.2
BMPR1A
NM_001406559.1
c.-267-25895T>C
intron
N/ANP_001393488.1
BMPR1A
NM_001406560.1
c.-267-25895T>C
intron
N/ANP_001393489.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMPR1A
ENST00000372037.8
TSL:1 MANE Select
c.-267-25895T>C
intron
N/AENSP00000361107.2
BMPR1A
ENST00000480152.3
TSL:3
c.-372-25895T>C
intron
N/AENSP00000483569.2
BMPR1A
ENST00000713672.1
c.-153+56051T>C
intron
N/AENSP00000518974.1

Frequencies

GnomAD3 genomes
AF:
0.137
AC:
20823
AN:
152090
Hom.:
1899
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0375
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.225
Gnomad ASJ
AF:
0.0738
Gnomad EAS
AF:
0.109
Gnomad SAS
AF:
0.145
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.124
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.137
AC:
20847
AN:
152208
Hom.:
1909
Cov.:
32
AF XY:
0.137
AC XY:
10189
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0374
AC:
1554
AN:
41558
American (AMR)
AF:
0.226
AC:
3461
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0738
AC:
256
AN:
3470
East Asian (EAS)
AF:
0.108
AC:
562
AN:
5184
South Asian (SAS)
AF:
0.145
AC:
698
AN:
4810
European-Finnish (FIN)
AF:
0.164
AC:
1735
AN:
10596
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.178
AC:
12093
AN:
67990
Other (OTH)
AF:
0.126
AC:
265
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
867
1733
2600
3466
4333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
3971
Bravo
AF:
0.137
Asia WGS
AF:
0.143
AC:
498
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.4
DANN
Benign
0.62
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12415784; hg19: chr10-88572727; API